CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 54 filers reported holding CLEARSIDE BIOMEDICAL INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $100,000 | +212.5% | 36,239 | +73.4% | 0.00% | +33.3% |
| Q3 2020 | $32,000 | -25.6% | 20,900 | -8.7% | 0.00% | -25.0% |
| Q2 2020 | $43,000 | +10.3% | 22,900 | 0.0% | 0.00% | -20.0% |
| Q1 2020 | $39,000 | -66.9% | 22,900 | -43.7% | 0.01% | -50.0% |
| Q4 2019 | $118,000 | +202.6% | 40,700 | -33.7% | 0.01% | +150.0% |
| Q3 2019 | $39,000 | -33.9% | 61,400 | +0.7% | 0.00% | -33.3% |
| Q2 2019 | $59,000 | -30.6% | 61,000 | -0.8% | 0.01% | -33.3% |
| Q1 2019 | $85,000 | +25.0% | 61,500 | -2.8% | 0.01% | 0.0% |
| Q4 2018 | $68,000 | -85.4% | 63,300 | -16.2% | 0.01% | -83.0% |
| Q3 2018 | $465,000 | +36.0% | 75,550 | +54.8% | 0.05% | +26.2% |
| Q4 2017 | $342,000 | +33.6% | 48,812 | +66.5% | 0.04% | +27.3% |
| Q3 2017 | $256,000 | – | 29,312 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 3,917,622 | $7,365,000 | 0.21% |
| GSA CAPITAL PARTNERS LLP | 54,092 | $102,000 | 0.06% |
| Carmignac Gestion | 1,937,608 | $3,643,000 | 0.05% |
| OXFORD FINANCIAL GROUP, LTD. LLC | 91,824 | $173,000 | 0.03% |
| SIGNATUREFD, LLC | 121,351 | $228,000 | 0.01% |
| Tekla Capital Management LLC | 165,330 | $311,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 184,000 | $346,000 | 0.01% |
| GROUP ONE TRADING, L.P. | 567,903 | $1,068,000 | 0.01% |
| Integrated Advisors Network LLC | 15,700 | $30,000 | 0.00% |
| WEDBUSH SECURITIES INC | 22,900 | $43,000 | 0.00% |